Company Profile

Novo Biosciences Inc (AKA: Revidia Therapeutics Inc)
Profile last edited on: 2/20/2023      CAGE: 6XGH9      UEI: W129EFQ5LL71

Business Identifier: Small molecule therapies that reactivate and stimulate healing abilities
Year Founded
2013
First Award
2017
Latest Award
2018
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

164 Old Bar Harbor Road
Bar Harbor, ME 04609
   (207) 288-5684
   N/A
   www.novobiosciences.com
Location: Single
Congr. District: 02
County: Hancock

Public Profile

Organized around the potential of regenerative medicine, the first spinoff of form the MDI Biological Laboratory in Bar Harbor, ME., Novo Biosciences is primarily focused in its early work on investigating the regenerative abilities of Zebrafish - a unique species able to regrow fins, tail and even heart muscle. Tissue damage in humans factors to major lost economic productivity, diminished quality of life, and premature death. Development of a technology that could enhance tissue repair would be invaluable. Early investigation by Novo Bioscience has identified a compound common both to the zebra fish and to humans. The firm has further identified a small molecule that apeears significantly to amplify and hasten regeneration of complex limb tissues and heart muscle.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
.5M-1M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Key People / Management

  Kevinofficer Strange -- Chief Executive Officer

  Viravuth Yin